Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.64 USD | -1.41% |
|
+0.82% | +13.03% |
Jun. 02 | UBS Adjusts Price Target on Exelon to $48 From $46, Maintains Neutral Rating | MT |
May. 29 | Exelon's ComEd Unit Gets Approval for $168 Million Plan to Support EV Adoption in Illinois | MT |
Summary: Exelon Corporation
- The company presents an interesting fundamental situation from a short-term investment perspective.
Highlights: Exelon Corporation
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses: Exelon Corporation
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 3.86 times its current sales, is high.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings Chart: Exelon Corporation
Source: Surperformance
ESG chart: Exelon Corporation
Source: MSCI
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
43.66B | |||||
154B | |||||
131B | |||||
117B | |||||
99.3B | |||||
93.69B | |||||
93.05B | |||||
90.83B | |||||
58.96B | |||||
54.97B | |||||
Average | 93.61B | ||||
Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
AA
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
ESG: Environment
ESG: Social
ESG: Governance
ESG: Controversy
ESG: Ethical controversies
ESG: Human rights controversies
ESG: Tax subsidies controversies
ESG: Sharia compliant
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EXC Stock
- Ratings Exelon Corporation
Select your edition
All financial news and data tailored to specific country editions